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Background: The emergence of resistance to vancomycin, the drug of choice 
against methicillin-resistant Staphylococcus aureus, in enterococci has 
increased the need for new antibiotics. As chemical modification of the 
antibiotic structure is not trivial, we have initiated studies towards enzymatic 
modification by sequencing the DNA coding for the biosynthesis of 
chloroeremomycin (also known as A82846B and LY264826). 
Results: Analysis of 72 kilobases of genomic DNA from Amycolatopsis 
orientalis, the organism that produces chloroeremomycin, revealed the 
presence of 39 putative genes, including those coding for the biosynthesis of 
the antibiotic. Translation and subsequent comparison with known proteins in 
public databases identified enzymes responsible for the biosynthesis of the 
heptapeptide backbone and 4-ep;-vancosamine, as well as those for 
chlorination and oxidation reactions involved in the biosynthesis of 
chloroeremomycin. 
Conclusions: The genes responsible for the biosynthesis of chloroeremomycin 
have been identified, and selective expression of these genes could lead to the 
synthesis of new potent glycopeptide antibiotics. 
Introduction 
Vancomycin (1, Figure 1) and teicoplanin are the antibi- 
otics of choice against methicillin-resistant S~afvi~Lucoccu.s 
aweus (MRSA) [l]. Vancomycin-resistant enterococci 
(VRE) currently cause problems as hospital pathogens, 
increasing the need for antibiotics active against VRE 
[Z-4]. Our research has been directed towards a better 
understanding of the molecular mode of action of van- 
comycin group antibiotics and has led to a generally 
accepted model. The model includes the molecular basis 
of binding to mucopeptide cell wall precursors terminat- 
ing in -Lys-t>-Ala-lj-Ala, the importance of dimerisation 
of the antibiotic, which is promoted by the presence of 
sugar residues and chlorine atoms, and the importance of 
membrane anchoring in the case of teicoplanin [S]. It 
appears that these findings, taken collectively, can 
account for the remarkable activity of a new semi-syn- 
thetic glycopeptide antibiotic, derived from chloroere- 
momycin (2, also known as A82846B and LY264826), 
against VRE [6]. 
As modifications of the glycopeptide antibiotics via stan- 
dard organic synthetic pathways are somewhat restricted, 
we decided to sequence the DNA that is thought to code 
for the biosynthesis of chloroeremomycin (Z), with a view 
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to using the identified enzymes to produce new gly- 
copeptide antibiotics (e.g. by introducing desirable struc- 
tural features onto the heptapeptide backbone). The 
peptide backbone is a conserved feature of the glycopep- 
tide antibiotics, although different amino acids are fre- 
quently found for different antibiotics at residues 1 and 
3 (numbering from the amino terminus). For chloro- 
eremomycin, the backbone is based on H2N-R-Leu-R- 
Tyr-S-Asn-R-HPG-R-HPG-S-Tyr-S-DHPG-OH (HPG, 
4-hydroxyphenylglycine; DHPG, 3,5dihydroxyphenyl- 
glycine; R and S indicate the absolute configuration at 
the a carbon of the amino acids, Figure 1) [5]. Previous 
research in our group has shown that for vancomycin 
(and hence, by analogy, probably also for chloroere- 
momycin) and ristocetin A, the DHPG moieties are 
derived from acetate, probably via a polyketide mecha- 
nism [7], whereas the HPG residues are derived from 
tyrosine [7,8]. 
Recently, identification and expression of three glycosyl 
transferases, involved in the introduction of the sugar 
moieties onto chloroeremomycin, have been reported [9]. 
It was shown that these enzymes could be used to 
produce new glycopeptide antibiotics. In this paper, we 
describe the sequencing and analysis of 72 kilobases (kb) 
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Figure 1 
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Structures of vancomycin (1) and chloroeremomycin (2). 
of genomic DNA from Amycolatopsis orientalis, the organ- 
ism that produces chloroeremomycin. This sequence 
includes not only the genes coding for the above-men- 
tioned glycosyl transferases, but also most of the remain- 
ing genes coding for the biosynthesis of chloroeremo- 
mycin. This is the first report of a relatively complete 
biosynthetic pathway to a vancomycin group antibiotic. 
Analysis of the identified genes not only leads to a better 
insight into the steps involved in the biosynthesis, but 
expression of suitable enzymes of the pathway may allow 
the synthesis of new antibiotics that could help to fight 
VRE, and possibly also vancomycin-resistant S. amem 
(VRSA). Furthermore, the work will facilitate the charac- 
terisation of enzymes responsible for the introduction of 
special structural features present in vancomycin group 
antibiotics (such as aromatic ether and biaryl linkages, 
and chlorine substituents) that are themselves of wide 
interest. 
Results and discussion 
Compositional organisation and location of the proteins 
Both cosmids used for the present sequencing work 
(pCZA361 and pCZA363) [9] are rich in GC, with a GC 
content of -68%. The most commonly found start codon 
in the two cosmids is ATG (90%); TTG seems to be the 
start codon for one enzyme (ORF8) and GTG is found for 
the remaining enzymes. 
Analysis of the 72 kb genomic DNA led to the location of The coding sequence for the three peptide synthetases 
39 putative proteins; 9 on cosmid pCZA363 and 30 on CepA, CepB, and CepC spans 27 kb at the start of the reg- 
cosmid pCZA361. The results are summarized in Figure 2. ion of the bacterial genome linked with antibiotic biosyn- 
The genes on cosmid pCZA363 are all found on the same thesis. These putative enzymes have 3158, 4077 and 1860 
DNA strand, whereas six of the genes on cosmid pCZA361 amino acids, respectively. The protein sequence of each 
are located on the opposite strand. was analysed for the presence of standard motifs present in 
Enzymes and reactions involved in the biosynthesis of 
chloroeremomycin 
Peptide synthetases 
Analysis of the sequence revealed that three putative pro- 
teins have very significant homology to existing peptide 
synthetases, a class of large multienzymes that catalyse the 
formation of small peptides by a non-ribosomal route [lo]. 
Examination of the protein sequences of these enzymes 
has indicated that they consist of structural modules, each 
of which is responsible for activating and binding one of 
the constituent amino acids. These modules are organised 
in an order that is colinear with the amino acid sequence 
of the peptide [lo-121. 
The process by which the peptide is synthesised is 
known as the multienzyme thiotemplate mechanism 
[10,13,14]. In the first step, the component amino acids 
are activated as aminoacyl adenylates. Each amino acid is 
then covalently linked to an enzyme-attached 4’-phos- 
phopantetheine cofactor by thioesterification [14,15]. 
Peptide synthesis occurs by amide bond formation at 
the contact sites of the activating domains. Here, the 
growing peptide chain is transferred from the 4’-phos- 
phopantetheine of one enzyme module to the next, each 
time increasing in length by one amino acid. Finally, the 
completed peptide is released from the last domain by 
thioesterase scission. 
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Figure 2 
Representation of the open reading frames 
(ORFs) located on cosmids pCZA361 
(1 O-39) and pCZA363 (l-9). 
( 3ene homologies 
1 2 3 (CepA) L 
F b 
4 (CepB) 
b 
5 (WC) 67 8 9 10 11 (GtfA) 
bW 
L 
F F F 
12(GtfB)13(GtfC) 14 15 16 17 18 19 20 21 
c c 
r L- 
22 23 24 25 26 27 28 29 30 31 32 
m Peptide synthetases m Halogenases 
i Glycosyl transferases m Other genes 
m Sugar biosynthesis genes m No significant homologies 
m Oxidative genes 
H 
1000 
base pairs 
Chemstry & Biology 
other peptide synthetases (for a summary see Kleinkauf tienzymes responsible for assembling a heptapeptide. 
and Von Dohren [lo]), and homology searches were per- This organisation closely resembles that of previously 
formed to allow the different functional domains to be iden- discovered peptide synthetases such as those for sur- 
tidied. The results of this analysis are shown in Figure 3. factin (SrfAl, SrfA2 and SrfA3) and gramicidin (GrsA and 
GrsB) [12,16,17]. 
It can be seen that there are seven modules of similar 
functional organisation (three in CepA, three in CepB Four of the seven constituent amino acids (1,2,4 and 5) of 
and one in CepC), as would be expected for a set of mul- chloroeremomycin have the R-configuration, so it might 
Figure 3 
Schematic representation of the functional 
organisation of the three peptide synthetases, 
CepA, CepB and CepC. The numbers 
indicate sequentially the amino-acid-activating 
domains on each peptide synthetase. 
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be expected that four domains with epimerisation char- 
acter could be identified in the three peptide syn- 
thetases. This is the case for modules 2, 4 and 5, but not 
for module 1 (Figure 3), suggesting the possibility that, 
in fact, it is R-leucine that is accepted by CepA. 
A further facet of the organisation of these peptide syn- 
thetases is the unusual nature of the transfer of the 
growing peptide chain between the individual multi- 
enzymes. For both the transfer of tripeptide between 
CepA and CepB, and hexapeptide between CepB and 
CepC, the carboxy-terminal amino acid of the peptide 
being transferred has the S-configuration. This contrasts 
with all but one of the previously characterised peptide 
synthetase systems, such as those for surfactin and grami- 
cidin [l&16,17], where interenzymatic transfers occur with 
peptides in which the carboxy-terminal amino acid has the 
R-configuration. The only other example of the unusual 
S-peptide transfer is provided by the recently charac- 
terised bacitracin peptide synthetases from the hat operon 
of Bacillus lidzeniformis [18]. The internal epimerisation 
domains of CepA and CepB are also a feature shared with 
these multienzymes. 
It was proposed by Cosmina et al. [16] that an -180 
amino acid region in the adenylation domain of each 
module is responsible for specific amino acid recognition. 
For each of the seven modules, these regions were com- 
pared both with each other, and with corresponding 
regions in other peptide synthetases. Significant results 
from these comparisons are shown in Table 1. 
The evidence provided by these comparisons, taken in con- 
j&ction with the feeding experiments mentioned previ- 
ously [7,8], allows us to infer that the amino acids used for 
residues 2 to 7 are, respectively, S-tyrosine, S-asparagine, 
S-Chydroxyphenylglycine, S-Chydroxyphenylglycine, S-ty- 
rosine and S-3,5-dihydroxyphenylglycine. Interestingly, the 
region that recognises the amino-terminal acid does not 
show good homology with other S-leucine regions. This 
could be because the region recognises R-leucine rather 
than S-leucine, as proposed above. 
The genes for the synthesis of the ‘non-standard’ amino 
acids are not found on the two cosmids. The finding that 
ORFl, a prephenate dehydrogenase, is at the start of 
pCZA363, however, might indicate that these genes are 
clustered to the left of the 5’ end of cosmid pCZA363. We 
propose that the introduction of the /3-hydroxyl groups on 
the tyrosine residues, and chlorination and cross-linking of 
the different amino acid sidechains occurs after assembly 
of the peptide backbone. 
Oxdative reactions 
To convert the linear heptapeptide derived as above to 
the unglycosylated chloroeremomycin nucleus requires 
Table 1 
Significant homologies for the seven amino-acid-recognition 
domains present in the three peptide synthetases. 
Amino acid 
1 : N-Me-R-Leu 
2 : R-CH-Tyr 
3 : S-Asn 
4 : R-HPG 
5 : R-HPG 
6 : S-CH-Tyr 
7 : S-DHPG 
Significant homologies (% similarity,Yo identity) 
Amino acid 5 recognition (69%, 61%)* 
Pristinamycin PG recognition (580/o, 50%) 
Pristinamycin Abu recognition (540/o, 49%) 
Amino acid 6 recognition (63%, 57%) 
Virginiamycin Phe recognition (52%, 48%) 
Pristinamycin DMPA recognition (48O/o, 43%) 
Surfactin Asp recognition (49%,370/o) 
Amino acid 5 recognition (73%, 69%) 
Amino acid 7 recognition (64%, 58%) 
Pristinamycin PG recognition (530/o, 47%) 
Amino acid 4 recognition (73O/o, 69O/o) 
Amino acid 7 recognition (66%, 61 O/o) 
Pristinamycin PG recognition (510/o, 43%) 
Amino acid 2 recognition (63%, 57O/o) 
Virginiamycin Phe recognition (50010, 45%) 
Pristinamycin DMPA recognition (46%, 40%) 
Amino acid 5 recognition (66%, 61%) 
Amino acid 4 recognition (64%, 580/o) 
Pristinamycin PG recognition (510/o, 43%) 
‘J/o Similarities and O/o identities are over the whole region between the 
motifs C and E of Kleinkauf and Von Dtihren [lo] in all cases and were 
obtained using the GAP program of the GCG package. Where 
homologies are described in terms of ‘Amino acid’ and a number, 
these refer to the constituent amino acids of chloroeremomycin. 
*Amino acid 1 recognition domain also shows significant homologies 
(-600/o similarity) with domains recognising amino acids 4 and 7. Abu, 
aminobutyric acid; CH-Tyr, m-chloro$hydroxytyrosine, DMPA, 
cc-N-methyl-4-dimethylaminophenylalanine, PG, phenylglycine; HPG, 
4-hydroxyphenylglycine; DHPG, 3,5-dihydroxyphenylglycine. 
several oxidative processes. These include the introduc- 
tion of P-hydroxyl groups onto tyrosine residues 2 and 6 
and coupling of rings 5 and 7, rings 4 and 6, and rings 4 
and 2. Furthermore, it is likely that the chlorine atoms on 
rings 2 and 6 are introduced via oxidative processes, that is 
using a haloperoxidase. Together, these processes should 
require at least seven enzymes. 
Analysis of the enzymes found on the two cosmids shows 
that there are eight enzymes (ORFs 7, 8, 9, 10, 14, 18, 20 
and 21) that might be involved in these oxidations. Four 
of these, ORF7, ORF8, ORF9 and ORFZO, are P4SO- 
related enzymes, and contain an iron-heme binding motif 
(FGHGxHxCLG). They show identity scores ranging 
from 26% to 34% compared to similar enzymes found, for 
example, in Streptomyces hygr-oscopk [ 191 or Badus suh- 
MS [ZO]. Two ORFs (10 and 18) show homology to non- 
heme haloperoxidases. ORFs 9 and 14 were previously 
identified as putative hydroxylation enzymes [9]. ‘I’hus, 
the identified enzymes seem to be sufficient to carry out 
the expected oxidations, although there appears to be one 
enzyme present that is in addition to the requirements 
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Figure 4 
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NDP-4-keto-6-deoxyglucose 
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NH, NH2 
NDP-4-epi-vancosamine 
Postulated route for the biosynthesis of NDP-4-epi-vancosamine starting from NDP-4-keto-6-deoxyglucose, with the corresponding putative 
enzymes involved. The putative involvement of the pyridoxamine cofactor is shown in brackets. 
identified above. The exact function of each individual 
enzyme remains to be elucidated. 
Chlorination 
Chloroeremomycin contains chlorine atoms on residues 2 
and 6. It is most likely that there are two enzymes respon- 
sible for the chlorination, because eremomycin (also 
known as MM45289) contains a chlorine atom on residue 
2 only [Zl]. Indeed, two enzymes located on cosmid 
pCZA361 show homology to non-heme haloperoxidases. 
ORF18 shows identity scores ranging from 24% to 29% 
compared to known haloperoxidases found in Streptom~~ces 
lividans [Z&23]. Only the first 150 amino acids of ORFlO 
show homology with a known haloperoxidase found in 
Pseudomonas fhorescem (identity score 20%) [24]. The rela- 
tively low homologies may reflect the special character of 
these enzymes. 
Glycosyl transferases 
Once the cyclised and oxidised peptide core is available, 
two molecules of 4-epi-vancosamine and one of glucose must 
be added to it at specific sites. This process should require 
three enzymes and indeed three glycosyl transferases are 
located on pCZA361 (available under accession number 
IJ84349), annotated as GtfA (ORFll), GtfB (ORFlZ), and 
GtfC (ORF13) [9]. Furthermore, homology was found 
between these three glycosyl transferases and two glycosyl 
transferases involved in vancomycin biosynthesis [9]. 
Expression of one these genes C.ggB) showed that GtfB is 
capable of introducing glucose onto a heptapeptide core [9]. 
Biosynthesis of 4-epi-vancosamine 
Inspection of the gene clusters of other secondary meta- 
bolites such as daunorubicin and erythromycin [25,26] 
suggested that the genes that code for the biosynthesis of 
the unusual 4-epi-vancosamine sugar (4-e-V) should be 
located in the same region as other biosynthetic genes, 
and this did indeed prove to be the case. On the basis of 
analogy to the biosynthesis of other h-deoxysugars 
[26-Z], the biosynthesis should proceed through an 
NDP-4-keto-6-deoxyglucose intermediate. Enzymes for 
the production of this key intermediate were not identi- 
fied in the cluster, but it is possible that general cellular 
pools of this precursor are used for the biosynthesis of 
4-e-V, an idea recently postulated by Summers et a/. [26] 
for the biosynthesis of the mycarose and desosamine 
sugars of erythromycin. 
Given NDP-4-keto-6-deoxyglucose as a precursor, homolo- 
gies to enzymes identified in the biosynthetic pathways for 
daunosamine and mycarose [26,28,29] allowed a probable 
route to 4-e-V to be deduced (Figure 4). Four putative 
enzymes were identified. ORFZ6 was assigned as a 
3,5-epimerase on the basis of its strong homology to DnmIJ 
(60% identity) of the daunosamine pathway of Streptomyces 
peucetizls [ZB] and EryBVII (55% identity) of the mycarosc 
pathway of SacdaropoJvspora e@iraea [26]. ORF23 is 
closely related to DnmT (49% identity) from the 
daunosamine pathway of S. peucedus [29] and EryBVI (45% 
identity) from the mycarose pathway of S. er@raea [26], 
both of which have been linked with C2 deoxygenation. 
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Table 2 
Summary of genes identified on cosmids PCZA361 and PCZA363 obtained from Amycolatopsis orientalis. 
ORF 
(name) 
Position in 
base pairs 
(cosmid / 
start..stop) 
Size 
(amino acids) 
Proposed function 
/homology 
1 363/255..1358 367 
2 363/l 562..3514 650 
3 (CepA) 36313511 ..12987 3158 
4 (Cep B) 363/l 3162..25395 4077 
5 Cep C) 363/25415..30997 1860 
6 363/31033..31203 56 
7 363/31325..32500 391 
8 363/32673..33740 355 
9 363133?91..35143 450 
10 361/1076..2551 491 
11 (GtfA) 361/2596..3786 396 
12 (GtfB) 361 I3821 ..5044 407 
13 (GtfC) 361 I51 93..6422 409 
14 361/6495..7721 408 
15 361/7732..8556 275 
16 361/8589..9431 281 
17* 36119400..10935 511 
18 361 I1 0934..11764 276 
19 361111761..13503 580 
20 361113519..14712 397 
21 361 I1 4957..16030 357 
22 361116027..17100 357 
23 361/17100..18515 471 
24 361/18517..19494 325 
25 361 I1 9491..20600 369 
26 361120624..21241 205 
27 361/21434..22552 372 
28 361122552..23352 217 
29 361/23511..24647 378 
30 361/24644..25447 267 
31 361/25569..26657 362 
32* 361/26664..28190 508 
33 361128418..32428 1336 
34 361132572..32874 100 
35 361/32901..33746 281 
36* 361133785..34333 183 
37* 361134355..35743 462 
38* 361135740..37227 495 
39* 361137530..37928 132 
Accession numbers of 
selected homologous 
proteins 
Prephenate dehydrogenase 
MdrlABC transporter 
Peptide synthetase+ 
Peptide synthetase+ 
Peptide synthetase+ 
Hypothetical protein 
in M. tuberculosis 
P450-related oxidase* 
P450-related oxidase* 
P450-related oxidase* 
Non-heme halogenase 
Glycosyl transferase 
Glycosyl transferase 
Glycosyl transferase 
Hydroxylase 
? 
Methyl transferase 
Amino transferase 
Non-heme halogenase 
Peptide synthetase+ 
P450-related oxidase* 
Hydroxyphenyl 
Pyruvate dioxygenase 
Glycolate oxidase 
2,3 Dehydratase 
4-Ketoreductase 
Sugar biosynthesis 
3,5-Epimerase 
Chalcone synthase 
? 
Carnitine racemase 
Carnitine racemase 
Phospho-2-dehydro-3- 
Deoxyheptonate aldolase 
? 
? 
? 
? 
? 
? 
Endolexo gluconase 
precusor 
Sugar transporter 
P20692, D90910 
P45861, U78609 
X98690, S46968 
X98690,140485 
X98690, Yl1547 
295208 
/ 
P46373, P23296 
P46373, Sl5809 
P46373, P18327 
u74493 
U84350, U77459 
U84350, X81 885 
U84350, U77459 
S39963, Si 8530 
U77549, U21300 
Y08257 
P29715, AF031242 
X98690, Y11547 
P53554, s49051 
Ull864, S32821 
Dl4044, U80071 
U77891, U77459 
u77459 
P25048 
AF006631, U77459 
P54157, x91340 
P31551 
P31551 
P44303, Q09755 
P54583, P50899 
D90910, D90769 
Typical 
homology 
(o/o similarity, 
O/o identity) 
(36%, 24%) 
(450/o, 32%) 
(41 o/o, 32%) 
(41 O/o, 32%) 
(430/o, 36%) 
(86%,74%) 
(39%, 30%) 
(470/o, 39%) 
(47%, 38%) 
(300/o, 2 1 O/o) 
(75%, 63%) 
(88%, 82%) 
(750/o, 69%) 
(56%, 48%) 
(3 1 O/o, 2 7%) 
(44%, 32%) 
(32%, 26%) 
(52%,47%) 
(350/o, 27%) 
(430/,,34%) 
(50%, 400/o) 
(58%, 49%) 
(560/o, 490/o) 
(770/o, 720/o) 
(69%, 60%) 
(370/o, 28%) 
(3990, 30%) 
(52O/o, 41 O/o) 
(57%,480/o) 
(24%, 20%) 
(500/o, 29%) 
*Gene on opposite strand. Contains these motifs from the PROSITE 
dictionary of protein sites and patterns: YTSGSTGXPK (AMP binding) 
ELGGDSIXMXXXARA (4’-phosphopantetheine attachment site). 
*Contains this motif from the PROSITE dictionary of protein sites and 
patterns: FGHGXHXCLG (cytochrome P450 cysteine heme-iron 
ligand signature). 
In particular, EryBVI was assigned as a 2,3-dehydratase using ORFZS or if another enzyme is necessary. ORF16 
and a similar role is proposed for ORF23. ORF25 has shows some homology with known methyl transferases, 
impressive homology (72% identity) to DnrJ, an enzyme and might therefore be involved in this step. The pro- 
found in daunosamine biosynthesis and implicated in the posed biosynthesis is completed by C-4 ketone reduction 
introduction of the amine group [25,27], probably with with ORF24, which has strong homology only to EryBIV 
the aid of pyridoxamine as a cofactor. At this stage, it (49% identity), the 4-ketoreductase of the mycarose 
remains unclear whether the methyl group is introduced pathway of S. ery&zea [26]. 
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The remaining proteins 
There is no clearly defined role for the remaining puta- 
tive proteins in the biosynthesis of chloroeremomycin. 
The Supplementary material includes comments on the 
relevant ORFs. 
The results from the analysis of the two cosmids pCZA361 
and pCZA363 are summarized in Table 2. The enzymes 
identified on cosmids pCZA361 and pCZA363 seem suffi- 
cient to account for all, or most, of the steps involved in 
the biosynthesis of chloroeremomycin, given the provision 
of activated glucose and the required amino acids. 
Significance 
We have sequenced two overlapping cosmids spanning a 
total of 72 kb of genomic DNA originating from Amyco- 
latopsis orientalis, the organism responsible for the produc- 
tion of the glycopeptide antibiotic chloroeremomycin. 
Analysis of the sequence led to the identification of 39 
putative genes, including those coding for enzymes 
responsible for the biosynthesis of the antibiotic. The 
enzymes responsible for the biosynthesis of the aryl 
ethers, the biaryl linkage, P-hydroxylation of tyrosine 
residues, and introduction of the chlorine substituents are 
probably coded for within the 72 kb that have been 
sequenced. These enzymes are of special interest because 
their mechanisms are poorly understood. Expression of 
selected genes should give enzymes that could be used for 
the modification of glycopeptides, leading to new drugs to 
combat the increasing antibiotic resistance in bacteria. 
Materials and methods 
Preparation and isolation of the two cosmids pCZA361 and 
pCZA363 (both in Escherichia co/i S17-1) was described by Solen- 
berg et al. [91. An overlap of 5 kb between the two cosmids was con- 
firmed by the sequence data, showing that the two cosmids cover 
72 kb of contiguous DNA. 
Sequencing 
Individual colonies from the two clones (pCZA361 and pCZA363) were 
inoculated into 2 x TY medium with apramycin (50 Kg/ml) and grown to 
saturation. DNA was prepared from these cultures by alkaline lysis [301, 
followed by CsCl/ethidium bromide density gradient ultracentrifugation. 
Approximately 15 pg of DNA were sonicated and fragments were blunt- 
ended with mung bean nuclease. Fragments in the size range 1.4 to 
2 kb were isolated from agarose gels using Prep-A-Gene (Biorad). An 
aliquot of the isolated fragments was ligated into pUCl8 cut with Smal 
and dephosphorylated. Fractions of the ligation were transformed into f. 
co/i TGl cells by electroporation. Recombinants were selected by 
plating onto medium containing ampicillin (100 pglml), IPTG and Xgal, 
and were prepared for sequencing. 
The sequencing strategy involved two phases. Approximately 400 
random pUC18 subclones were selected from each cosmid for 
sequencing. Double-stranded DNA was prepared using an alkaline 
lysis method (www.sanger.ac.uk.). Both ends of the DNA inserts were 
sequenced using dye-terminator chemistry, yielding on average 400 
bases of high quality data from each end. Approximately 600 good 
sequencing reads were collected from each cosmid and the random 
reads assembled automatically with the program PHRAP (P. Green, 
unpublished observations). In the second phase of sequencing, each 
assembly was subjected to human review to produce continuity of data 
and high accuracy (> 99.99%) At this point, discrepancies between dif- 
ferent sequence reads over the same region were resolved and addi- 
tional reads were obtained in a directed manner to recover sequence 
from both strands throughout the cosmids. 
Sequence analysis 
DNA sequence analysis was carried out within the environment of the 
ACEDB database (R. Durbin and J. Thierry-Mieg, A C. elegans Data- 
base. Documentation, code and data available from anonymous ftp 
servers at lirmm.lirmm.fr, cele.mrc-lmb.cam.ac.uk, and ncbi.nlm.nih.gov.). 
Protein coding sequences were detected by protein similarities deter- 
mined by BLASTX [31]. In the absence of protein similarities coding ele- 
ments were detected using hexamer coding statistics [32] using the 
program HEXEXON (R. Durbin, unpublished observations). Further 
analysis and comparison, including similarity and identity scores (using 
GAP), were carried out using the Wisconsin GCG package. Databases 
used include SWISS protein and TREMBL. 
Accession numbers 
The cosmid sequences have been deposited in the EMBL nucleotide 
databank, and are available under accession numbers AJ223998 
(pCZA361) and AJ223999 (pCZA363). 
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